Intrinsic Value of S&P & Nasdaq Contact Us

Evogene Ltd. EVGN

NASDAQ Global Market

SharesGrow Score
53/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.50
+331.6%

Evogene Ltd. (EVGN) current share price is $0.81. The gold spot price is $4,830.80 per troy ounce. Using the formula: EVGN in gold = $0.81 × 31.1035 ÷ $4,830.80 = 0.0052 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of EVGN when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding EVGN shares over the measured period.

EVGN in US Dollars
Gold in US Dollars
EVGN in Gold (grams per share)

Real Wealth Growth Rate

EVGN
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{EVGN}_{\text{gold}}(t) = \frac{P_{\text{EVGN}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{EVGN}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{EVGN}_{\text{gold}}^{(T)}}{\text{EVGN}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{EVGN}_\text{gold}^{(0)}$ = initial gold-price, $\text{EVGN}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

RCUS
RCUS
Arcus Biosciences, Inc.
$23.70
+3.00%
CRVS
CRVS
Corvus Pharmaceuticals, Inc.
$15.11
-0.92%
CKPT
CKPT
Checkpoint Therapeutics, Inc.
$4.26
+0.00%
CGEN
CGEN
Compugen Ltd.
$2.89
+0.35%
PLX
PLX
Protalix BioTherapeutics, Inc.
$2.38
+0.85%
FATE
FATE
Fate Therapeutics, Inc.
$1.29
-3.73%
ALDX
ALDX
Aldeyra Therapeutics, Inc.
$1.83
+2.23%
ICCC
ICCC
ImmuCell Corporation
$7.60
-1.68%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message